Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for $10.28 mn

The acquisition of the majority stake in Bayshore by Ipca Labs#39; wholly-owned subsidiary will enable the company to commercialise its registered generics drug products in the US market through this entity, Ipca Laboratories said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2P7Tdma